Driving reinvestment in R&D for antibiotics and advocating their responsible use

Economic Incentives for Antimicrobial Drugs Proposed by Duke-Margolis Centre

The Duke-Margolis Centre for Health Policy in the United States has released a paper describing U.S. policy approaches that could provide better economic incentives to antimicrobial developers that successfully bring effective drugs to the market while providing a societal benefit that exceeds the cost of the incentive. The paper, “Value-based strategies for encouraging new devleopment of antimicrobial drugs”, was released on 3 August with an accompanying viewpoint article in the Journal of the American Medical Association.

Click here to read the full paper.

Click here to read the Journal of the American Medical Association article.